Chembio Diagnostics Inventory Turnover Ratio 2006-2020 | CEMI

Chembio Diagnostics inventory turnover ratio from 2006 to 2020. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Chembio Diagnostics Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.094B $0.034B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $183.161B 34.37
Medtronic (MDT) Ireland $138.669B 26.12
Stryker (SYK) United States $76.844B 29.80
Boston Scientific (BSX) United States $53.421B 30.86
Lonza Group Ag (LZAGY) Switzerland $45.798B 0.00
Baxter (BAX) United States $40.316B 0.00
Terumo (TRUMY) Japan $30.009B 38.36
Zimmer Biomet Holdings (ZBH) United States $27.960B 23.20
EssilorLuxottica Societe Anonyme (ESLOY) France $27.740B 0.00
ResMed (RMD) United States $24.494B 35.51
Sunny Optical Technology (SNPTF) China $16.508B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.353B 0.00
Bio-Rad Laboratories (BIO) United States $14.962B 67.67
Insulet (PODD) United States $14.703B 622.11
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.255B 43.73
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.174B 10.60
Hill-Rom Holdings (HRC) United States $5.465B 13.56
Canopy Growth (CGC) Canada $5.268B 0.00
Haemonetics (HAE) United States $4.417B 29.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.388B 0.00
Neogen (NEOG) United States $3.998B 65.56
ICU Medical (ICUI) United States $3.904B 29.79
Envista Holdings (NVST) United States $3.806B 25.96
Abcam (ABCZY) $3.251B 0.00
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.118B 0.00
National Vision Holdings (EYE) United States $2.964B 460.63
NuVasive (NUVA) United States $2.522B 35.15
Agios Pharmaceuticals (AGIO) United States $2.380B 0.00
AtriCure (ATRC) United States $1.800B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.692B 0.00
NanoString Technologies (NSTG) United States $1.660B 0.00
Cardiovascular Systems (CSII) United States $1.446B 0.00
MacroGenics (MGNX) United States $1.355B 0.00
Owens & Minor (OMI) United States $1.299B 29.09
Aphria (APHA) Canada $1.221B 0.00
InMode (INMD) Israel $1.154B 29.10
Cerus (CERS) United States $1.010B 0.00
Quanterix (QTRX) United States $0.932B 0.00
PetIQ (PETQ) United States $0.912B 26.16
BioLife Solutions (BLFS) United States $0.840B 437.50
Lantheus Holdings (LNTH) United States $0.815B 11.30
OraSure Technologies (OSUR) United States $0.804B 0.00
Phibro Animal Health (PAHC) United States $0.722B 16.52
Meridian Bioscience (VIVO) United States $0.707B 16.34
LeMaitre Vascular (LMAT) United States $0.687B 41.95
Vapotherm (VAPO) United States $0.642B 0.00
Aurora Cannabis (ACB) Canada $0.583B 0.00
Zynex (ZYXI) United States $0.580B 50.61
Eagle Pharmaceuticals (EGRX) United States $0.566B 80.02
Omeros (OMER) United States $0.551B 0.00
Surmodics (SRDX) United States $0.522B 57.22
VAREX IMAGING (VREX) United States $0.472B 20.46
Viemed Healthcare (VMD) United States $0.341B 12.19
Cytosorbents (CTSO) United States $0.340B 0.00
HEXO (HEXO) $0.318B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.34
Surface Oncology (SURF) United States $0.252B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.241B 0.00
Organigram Holdings (OGI) Canada $0.204B 0.00
Female Health (VERU) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.164B 0.00
Chimerix (CMRX) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.141B 12.46
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.130B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.084B 0.00
Rockwell Medical (RMTI) United States $0.075B 0.00
United-Guardian (UG) United States $0.069B 15.40
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
Nephros (NEPH) United States $0.058B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.09
ImmuCell (ICCC) United States $0.040B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Senestech (SNES) United States $0.005B 0.00